Format

Send to

Choose Destination
Ann Pathol. 2014 Feb;34(1):64-9. doi: 10.1016/j.annpat.2014.01.006. Epub 2014 Feb 22.

[Pathologists and the French network of expertise on rare cancers ENT: The REFCORpath].

[Article in French]

Author information

1
Service d'anatomie pathologique, hôpital européen Georges-Pompidou, AP-HP, faculté Paris Descartes, 20-40, rue Leblanc, 75015 Paris, France. Electronic address: cecile.badoual@egp.aphp.fr.
2
Service d'anatomopathologie, institut de cancérologie Gustave-Roussy, 114, rue Édouard-Vaillant, 94805 Villejuif, France; Service d'anatomie et cytologie pathologiques, hôpital Lariboisière, AP-HP, faculté de médecine, université Paris Diderot, PRES Sorbonne Paris-Cité, 75010 Paris, France.
3
Service d'anatomie et cytologie pathologiques, hôpital Lariboisière, AP-HP, faculté de médecine, université Paris Diderot, PRES Sorbonne Paris-Cité, 75010 Paris, France.
4
Centre Lacassagne-IUFC, université Nice Sophia-Antipolis, 227, avenue de la Lanterne, 06200 Nice, France.
5
Pôle TCCR, clinique universitaire d'ORL, CHU de Grenoble, 1, avenue des Maquis-du-Grésivaudan, 38043 Grenoble 09, France.
6
Service de chirurgie tête et cou, institut de cancérologie Gustave-Roussy, 114, rue Édouard-Vaillant, 94805 Villejuif, France.
7
Service ORL-CCF, hôpital Tenon, AP-HP, université Paris-VI, 4, rue de la Chine, 75020 Paris, France.

Abstract

Aerodigestive tract tumors are very diverse, either in terms of location, or histologically. Also, this heterogeneity poses particular problems for the histological diagnosis but also for the establishment of the most appropriate treatment. Thus, the network REFCOR (réseau d'expertise français sur les cancers ORL rares/French expert network on rare ENT cancers) was created to better understand these issues, by proposing an epidemiological and diagnostic approach with research collaborations. This network is dedicated to all primary malignant tumors of the salivary glands, ear, nasal cavity and sinuses and all head and neck malignancies other than conventional squamous cell carcinoma. The REFCORpath network consists of expert pathologists and offers, through a network of scanned images, a second opinion or even a third.

KEYWORDS:

Cancer rare; Diagnostic; Expert; Expertise; Head and neck; Management; Network; ORL; Prise en charge; Rare tumor; Réseau

PMID:
24630638
DOI:
10.1016/j.annpat.2014.01.006
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center